Inhibikase Therapeutics (IKT) Non Operating Interest Expenses (2020 - 2022)
Inhibikase Therapeutics' Non Operating Interest Expenses was $5.00 in Q1 2022, down 100.0% from $11,797 a year earlier and down 96.8% from the prior quarter.
Powered by 
Analysis
Inhibikase Therapeutics (IKT) Non Operating Interest Expenses (2020 - 2022) Analysis & Trends
For FY2021, Non Operating Interest Expenses at Inhibikase Therapeutics came in at $19,923, down 32.2% from FY2020.
- In earlier years, Non Operating Interest Expenses was $29,402 in FY2020.
- The Q1 2022 figure marks the lowest quarterly Non Operating Interest Expenses in data going back to Q1 2020.
- Compared with a year earlier, Non Operating Interest Expenses has declined for four straight quarters, with an average decline of 47.7% over the last five quarters.
- Per Business Quant data, IKT's Non Operating Interest Expenses in the three quarters before Q1 2022 was $158.00 (Q4 2021), $157.00 (Q3 2021) and $7,811 (Q2 2021).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 217.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -477.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 653.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 269.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Inhibikase Therapeutics | 281.11 Mn | -420.36 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2022 | 5.00 |
| Dec 31, 2021 | 158.00 |
| Sep 30, 2021 | 157.00 |
| Jun 30, 2021 | 7,811.00 |
| Mar 31, 2021 | 11,797.00 |
| Dec 31, 2020 | 7,139.00 |
| Sep 30, 2020 | 6,890.00 |
| Jun 30, 2020 | 7,948.00 |
| Mar 31, 2020 | 7,425.00 |
API Access
Inhibikase Therapeutics Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=IKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "IKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=IKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();